Monday, March 21, 2022

National Academy Seeking Public Feedback on Use of Population Descriptors in Genomics Research

›
 The National Academy's Committee on Use of Race, Ethnicity, and Ancestry as Population Descriptors in Genomics Research is now actively...
Thursday, February 24, 2022

Retirement of CYP3A5 alleles in PharmVar

›
The PharmVar CYP3A5 expert panel has undertaken an extensive review of CYP3A5 allelic variation which led to the retirement of three star ...
Monday, February 21, 2022

Update to individual statin pathways to support release of new CPIC guidelines for statins

›
To coincide with the release of the updated CPIC guidelines for SLCO1B1, ABCG2 and CYP2C9 and statin-associated musculoskeletal symptoms , ...
Friday, February 18, 2022

CPIC Publishes Guideline for SLCO1B1, ABCG2, CYP2C9 and Statin Therapy

›
The CPIC guideline for SLCO1B1 , ABCG2 , and CYP2C9 and statin-associated musculoskeletal symptoms (SAMS) has been published in the journal...
Monday, February 14, 2022

Registration opens for CPIC-PGRN 2022 meeting in Denver, Colorado

›
We are excited to announce that registration is open for the 2022   CPIC-PGRN meeting: Diversifying PGx Science to Improve Implementation. T...
Tuesday, February 8, 2022

PharmGKB Heparin-Induced Thrombocytopenia Pathway published

›
A PharmGKB pathway of heparin-induced thrombocytopenia (HIT) has been published in Pharmacogenetics and Genomics. Heparin is a commonly use...
Wednesday, January 19, 2022

CPIC Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

›
The 2022 CPIC Guideline update for CYP2C19 Genotype and Clopidogrel Therapy is now published in Clinical Pharmacology and Therapeutics . Th...